Akso Health Group Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Akso Health Group (AHG) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2019
Period EndingDec 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2019
Operating Activities
Net Income-135.47-9.46-1.36-16.85-34.835.53
Depreciation & Amortization2.150.000.000.020.000.41
Deferred Income Tax-30.800.000.000.000.000.00
Stock Based Compensation0.000.000.000.390.060.00
Change in Working Capital3.022.06-1.17-7.57-0.20-15.34
Change in Accounts Receivable-0.860.33-8.100.000.000.00
Change in Inventory0.001.506.11-7.800.000.00
Change in Accounts Payable0.420.170.720.24-0.040.00
Change in Other Working Capital3.46-0.13-0.10-0.02-0.150.00
Other Operating Activities162.280.74-11.7212.7527.370.00
Net Cash from Operating Activities1.181.35-3.25-8.6310.06-1.73
Investing Activities
Capital Expenditures-0.150.000.000.000.00-0.94
Acquisitions-93.75-56.250.000.000.000.00
Sales/Maturities of Investments0.000.000.000.000.00-16.50
Other Investing Activities-12.010.000.000.040.00-50.67
Net Cash from Investing Activities-105.91-54.7218.47-19.960.00-68.11
Financing Activities
Debt Repayment0.00-7.69-27.51-10.00-10.000.00
Common Stock Issued195.88139.340.0010.020.00-1.32
Dividends Paid0.000.000.000.000.00-19.55
Other Financing Activities0.000.000.009.09-13.67-0.32
Net Cash from Financing Activities195.88131.65-27.5134.78-9.04-0.03
Summary
Effect of Forex Changes on Cash-1.12-1.27-0.440.610.00-5.38
Net Change in Cash90.0377.01-12.306.194.20-69.87
Cash at Beginning of Period86.209.1921.9315.130.00132.62
Cash at End of Period176.2386.209.1921.930.0057.37
Free Cash Flow1.021.35-3.25-8.6310.06-2.68
Supplemental Disclosures
Interest Paid0.000.110.340.682.110.00
Income Taxes Paid0.000.020.020.090.0012.25